12 February 2018 in Frontiers in Public Health
Ethical and legal considerations with regards to biometric data usage are directly related to the right to protection of personal data, which is part of the rights protected under the European Convention of human rights. Specific protection is required to the process and use of sensitive data which reveals certain personal characteristic and is related to the health status of individuals. Biometric data and information on individual upon which people could be identified based on specifics and distinguishing signs. Bulgaria, as a country progressing in terms of integration of digital technologies and as a European Union member state has adopted international and universal legal instruments related on the procession and use of digital data and data protection. On legislative and ethical grounds, it has been established the particular importance of not violating human rights and individual freedoms when processing and using personal data. It has been noted that the processing of special categories of personal data may be necessary for reasons of public interest in the field of public health and that is why under such circumstances it has been permitted the procession to be carried on without the consent of the data subject. Lack of transparency and lawfulness of the processing of personal data could lead to physical, tangible, or intangible damages where processing could lead to discrimination, identity theft, or identity fraud as a result of which may be significant adverse economic or social consequences. Increasingly, widespread use of biometrics in the implementation of medical activities requires the application of a new approach in terms of awareness regarding existing risks to the rights, ethics, and freedoms of all of us, as a user of medical service.
19 June 2016 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Rare diseases are diseases with a particularly low prevalence. The specificities of rare diseases - limited number of patients and scarcity of relevant knowledge and expertise - single them out as a distinctive domain of very high added value. The international reference for classification of diseases and conditions is the International Classification of Diseases (ICD), coordinated by the World Health Organization (WHO).\ud Patient registries and databases constitute key instruments for the development of clinical research in the field of rare diseases. Rare disease registries include not only diseases that are inherently rare, but also common diseases that are rare in specific populations, especially those defined by demographics.\ud Disease registries create the possibility of assessing the long-term safety and benefit of different treatments, perhaps leading to treatment algorithms that allow more choices for patients and clinicians
6 February 2018 in Journal of IMAB – Annual Proceeding (Scientific Papers)
27 March 2018 in Journal of IMAB – Annual Proceeding (Scientific Papers)
8 February 2017 in Journal of IMAB – Annual Proceeding (Scientific Papers)
The process of introduction into our national legislation of norms of the European union legislation has a direct impact on the process of realization of major activities in all spheres of the public life and the activities related to medical services are not an exception. \ud The management of activities, connected to provision of medical services, requires attention to be paid not only to the competitive environment, but also to the normative requirements, regulating the access of the citizens to medical aid. \ud When talking about healthcare and healthcare market, it should be noted that good healthcare is possible only where there is good civil society and strong traditions in the field of social insurance.\ud The new requirements introduced in the way of functioning of the healthcare system aim to provide improved human health, however simultaneously the adaptation of the system to the new legally regulated requirements should be implemented in a way, which guarantees fast and easy access to healthcare services for all patients
8 February 2017 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Marketing management in the sphere of health services is an activity, which has to do with evaluation of the potential (economic, demographic, morbidity etc.) in a given geographical region and with outlining the framework of a competitive and profitable business.\ud For the provision of effective management, a thorough economic analysis of the healthcare activities is necessary. With view to optimization of the results, economic evaluation at different levels needs to be made, including systematic consideration of the factors, which influence the decision for directing the resources to a given alternative use at the expense of other use.\ud The management of a healthcare enterprise is successful, only if the management of its individual units is successful and if they work in line with one another for the achievement of the common targets of the organization